Stocks · Health care · Pharmaceutical Preparations

AbbVie

ABBV Clue Score27
United States Fiscal year ends December CIK 0001551152 Results filed 30 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Brian L Durkin
20 Mar 2020
VP, Controller
Buy
750
$69.00
$51.75K
Brian L Durkin
20 Mar 2020
VP, Controller
Buy
800
$67.50
$54.00K
Brian L Durkin
18 Mar 2020
VP, Controller
Buy
2,200
$68.18
$150.00K
Edward J Rapp
3 Mar 2020
Director
Buy indirect
2,875
$87.87
$252.62K
Laura J Schumacher
16 Sep 2019
Vice Chairman
Buy
25,000
$70.42
$1.76M
Nicholas Donoghoe
29 Aug 2019
SVP, Enterprise Innovation
Buy
7,525
$66.19
$498.06K
Jeffrey Ryan Stewart
16 Aug 2019
SVP, US Commercial Operations
Buy
15,552
$64.44
$1.00M
Roxanne S Austin
1 Aug 2019
Director
Buy
25,000
$65.66
$1.64M
Roxanne S Austin
31 Jul 2019
Director
Buy
30,000
$66.02
$1.98M
Roxanne S Austin
30 Jul 2019
Director
Buy
10,000
$66.35
$663.50K
Henry O Gosebruch
29 Jul 2019
EVP, Chief Strategy Officer
Buy
30,000
$67.28
$2.02M
Roxanne S Austin
26 Jun 2019
Director
Buy
11,500
$67.50
$776.25K
William J Chase
26 Jun 2019
EVP, Finance & Administration
Buy
30,400
$67.30
$2.05M
Edward J Rapp
26 Jun 2019
Director
Buy
7,500
$67.30
$504.75K
Glenn F Tilton
27 Jun 2018
Director
Buy
5,400
$91.90
$496.27K
Edward J Rapp
20 Jun 2018
Director
Buy
1,013
$98.63
$99.91K
Showing 250 of 328 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 608
Amendments (4/A) skipped 10
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 15
Sales straight out of an exercise 137
Sales at will 157
Transactions with no price 0
Shares from compensation/vesting 13,007,465
Sales filed before the plan box existed 144
History held since 14 Dec 2012